AI model detects hidden diabetes risk by reading glucose spikes
To diagnose either type 2 diabetes or pre-diabetes, clinicians typically rely on a lab value known as HbA1c. This test captures a person’s average blood glucose levels over… read more.
To diagnose either type 2 diabetes or pre-diabetes, clinicians typically rely on a lab value known as HbA1c. This test captures a person’s average blood glucose levels over… read more.
The EMA revealed that Pfizer had withdrawn its application submitted on December 20, 2024, for variation to the marketing authorisation for Ngenla to treat adults with growth hormone… read more.
Optical coherence tomography (OCT), a tool routinely used to diagnose and plan treatment for eye diseases, has now been modified to collect images of the inner ear. A… read more.
A new study from researchers at the Indiana University Paul H. O’Neill School of Public and Environmental Affairs and the University of Notre Dame shows that per- and polyfluoroalkyl chemicals… read more.
AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been approved in the European Union (EU) for the treatment of adults with resectable non-small cell lung cancer (NSCLC) at… read more.
Nearly half of drug-caused deaths by healthcare workers involved drugs that were obtained from their place of work, new research finds. The study, published today in Addiction by academics from King’s… read more.
Amgen announced that the FDA has approved Lumakras (sotorasib) in combination with Vectibix (panitumumab) for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC), as… read more.
Americans who drink heavily are more than twice as likely to develop significant liver disease compared to 20 years ago, according to a new Keck Medicine of USC study published today… read more.
Emergency Medicine & Intensive Care
Urgent care visits commonly result in inappropriate prescriptions of antibiotics, glucocorticoids or opioids, according to a letter in the Annals of Internal Medicine. Michigan Medicine researchers examined commercial and Medicare… read more.
The first patient has been dosed in the DESTINY-Gastric05 phase IIII trial evaluating Enhertu (trastuzumab deruxtecan) in combination with a fluoropyrimidine chemotherapy (5-FU or capecitabine) and Merck’s anti-PD-1… read more.
Aging skin stretches, contracts and buckles under pressure – and that’s how wrinkles form, according to new experimental evidence from scientists at Binghamton University, State University of New… read more.
Today the American Geriatrics Society (AGS) announced the release of the Alternative Treatments to Selected Medications in the 2023 American Geriatrics Society Beers Criteria® (DOI: 10.1111/jgs.19500), an updated clinical… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.